Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001536368-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 9, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
10,000
Total Value
$345,351.35
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 5, 2026 | Sale | 7,779 | $34.28 | $266,659.45 | 54,105 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 5, 2026 | Sale | 1,867 | $35.36 | $66,012.08 | 52,238 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 5, 2026 | Sale | 354 | $35.82 | $12,679.82 | 51,884 | Direct | โ | View Details |